Rize Oncology Inc.
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 64.40K | 66.10K | 346.40K | 151.80K | 460.40K |
| Total Receivables | 110.90K | 158.90K | 151.70K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 153.10K | 181.10K | 73.80K | 126.10K | 197.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 328.50K | 406.00K | 571.90K | 278.00K | 658.30K |
|
|
|||||
| Total Current Assets | 328.50K | 406.00K | 571.90K | 278.00K | 658.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 328.50K | 406.00K | 571.90K | 278.00K | 658.30K |
|
|
|||||
| Total Accounts Payable | 133.90K | 114.20K | 117.10K | 6.70K | 8.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 169.80K | 67.40K | 9.00K | -- | -- |
| Total Other Current Liabilities | 169.80K | 67.40K | 9.00K | -- | -- |
| Total Current Liabilities | 303.70K | 181.50K | 126.10K | 6.70K | 8.80K |
|
|
|||||
| Total Current Liabilities | 303.70K | 181.50K | 126.10K | 6.70K | 8.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 303.70K | 181.50K | 126.10K | 6.70K | 8.80K |
|
|
|||||
| Common Stock & APIC | 6.80M | 6.76M | 6.75M | 6.36M | 6.36M |
| Retained Earnings | -6.53M | -6.32M | -6.09M | -5.87M | -5.50M |
| Treasury Stock & Other | -253.60K | -215.10K | -217.70K | -221.10K | -212.80K |
| Total Common Equity | 24.70K | 224.50K | 445.80K | 271.20K | 649.50K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.70K | 224.50K | 445.80K | 271.20K | 649.50K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.70K | 224.50K | 445.80K | 271.20K | 649.50K |
|
|
|||||